Delivery Order SPE2DB22D3301-SPE2DB25FZ0GT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This contract is a firm fixed price delivery order with a ceiling value of $17,849.85 and an ultimate completion date of October 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $17,849.85 on September 9, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ojjaara 200 mg tablets in packages of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $17,849.85 with firm fixed pricing and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same municipality....
- The Defense Logistics Agency awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 MG tablets in quantities of 30 units, with an ultimate completion date of October 14, 2025. The contract was competitively awarded without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for OJJAARA 200 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $35,699.72, represents a competitive award with no set-aside designation and is scheduled for completion by October 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in quantities of 30s, with a ceiling value of $35,699.72 under a firm fixed-price contract type. The delivery order, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive procurement action. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568062474 OJJAARA 200 MG TABLET UU 30S, with a ceiling value of $17,849.85. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0GTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $17,849.85 and an ultimate completion date of September 23, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, the company provides critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 9/2/25 |